Emmessar Biotech & Nutrition Schedules Board Meeting on May 12, 2026 to Approve Audited FY26 Financial Results

Emmessar Biotech & Nutrition Limited has notified the Bombay Stock Exchange of an upcoming Board of Directors meeting scheduled for Tuesday, May 12, 2026, at Mumbai. The intimation, dated May 05, 2026, has been filed pursuant to Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The primary agenda of the board meeting is to consider and approve the audited financial results of the company for the year ended March 31, 2026. The following table summarises the key details of the scheduled meeting:

Parameter: Details Meeting Date: Tuesday, May 12, 2026 Meeting Location: Mumbai Purpose: To consider and approve Audited Financial Results Period Under Review: Year ended March 31, 2026 Regulatory Reference: Regulation 29(1)(a), SEBI (LODR) Regulations, 2015 Intimation Date: May 05, 2026

Trading Window Closure

In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window for equity shares of Emmessar Biotech & Nutrition Limited will remain closed until May 14, 2026. The company had previously communicated this trading window closure to the exchange vide letter dated March 30, 2026.

The intimation has been signed by Priyanka Sharma, Company Secretary, on behalf of Emmessar Biotech & Nutrition Limited. The company's registered office and factory are located at Plot No. T-3/2, MIDC Area, Taloja – 410208, Dist. Raigad, Maharashtra.

Emmessar biotech & Nutrition Limited has formally communicated to the Bombay Stock Exchange that it does not meet the criteria to be classified as a large corporate under the applicable SEBI regulations. The company submitted this confirmation on April 08, 2026, addressing the requirements under SEBI circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated October 19, 2023.

Regulatory Compliance Disclosure

The company's disclosure relates to the SEBI framework concerning funding by large corporates, which establishes specific criteria for classification and compliance requirements. Emmessar Biotech & Nutrition Limited confirmed that it does not fall under the large corporate category as defined by the regulatory guidelines.

Financial Position Details

The company provided key financial and operational details as part of its regulatory submission:

Parameter: Details Company Name: Emmessar Biotech & Nutrition Ltd. CIN: L24110MH1992PLC065942 Outstanding Borrowing (March 31, 2025): NIL Credit Rating Status: Not Applicable Stock Exchange Fine Provision: Not Applicable

The company reported nil outstanding borrowings as on March 31, 2025, which supports its position regarding non-applicability of the large corporate framework. Additionally, credit rating requirements and stock exchange fine provisions related to borrowing shortfalls are marked as not applicable to the company's current operational structure.

Corporate Information

Emmessar Biotech & Nutrition Limited operates from its registered office and factory located at Plot No. T-3/2, MIDC Area, Taloja, Maharashtra. The company maintains its corporate office at Kamer Building in Fort, Mumbai. The disclosure was signed by Priyanka Sharma, serving as Company Secretary and Compliance Officer, ensuring proper authorization and compliance with regulatory requirements.

Regulatory Framework Context

The SEBI circular referenced in the disclosure establishes guidelines for funding mechanisms involving large corporates. Companies meeting specific criteria under this framework are subject to particular compliance requirements, including borrowing thresholds and credit rating obligations. By confirming its non-applicability status, Emmessar Biotech & Nutrition Limited clarifies its regulatory position and ensures transparency with market participants and regulatory authorities.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.